| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.10e-05 | 18 | 69 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.22e-04 | 28 | 69 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.82e-04 | 37 | 69 | 3 | GO:0045505 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 6.79e-05 | 4 | 71 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 2.36e-04 | 7 | 71 | 2 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 6.13e-04 | 11 | 71 | 2 | GO:0031906 | |
| GeneOntologyCellularComponent | dynein complex | 8.23e-04 | 54 | 71 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | symmetric synapse | 8.66e-04 | 13 | 71 | 2 | GO:0032280 | |
| Domain | NLGN4 | 1.35e-05 | 2 | 69 | 2 | IPR030025 | |
| Domain | Fam133 | 1.35e-05 | 2 | 69 | 2 | IPR026766 | |
| Domain | Nlgn | 1.34e-04 | 5 | 69 | 2 | IPR000460 | |
| Domain | Aspartic_peptidase_N | 2.79e-04 | 7 | 69 | 2 | IPR012848 | |
| Domain | A1_Propeptide | 2.79e-04 | 7 | 69 | 2 | PF07966 | |
| Domain | Cadherin_tail | 3.43e-04 | 37 | 69 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 3.43e-04 | 37 | 69 | 3 | IPR031904 | |
| Domain | Aspartic_peptidase_A1 | 5.94e-04 | 10 | 69 | 2 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 5.94e-04 | 10 | 69 | 2 | IPR033121 | |
| Domain | Asp | 5.94e-04 | 10 | 69 | 2 | PF00026 | |
| Domain | PEPTIDASE_A1 | 5.94e-04 | 10 | 69 | 2 | PS51767 | |
| Domain | - | 8.67e-04 | 12 | 69 | 2 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 8.67e-04 | 12 | 69 | 2 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 1.02e-03 | 13 | 69 | 2 | IPR001969 | |
| Domain | Carboxylesterase_B_CS | 1.02e-03 | 13 | 69 | 2 | IPR019819 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.19e-03 | 14 | 69 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.19e-03 | 14 | 69 | 2 | IPR024743 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.19e-03 | 14 | 69 | 2 | PS00941 | |
| Domain | MT | 1.19e-03 | 14 | 69 | 2 | PF12777 | |
| Domain | AAA_8 | 1.19e-03 | 14 | 69 | 2 | PF12780 | |
| Domain | COesterase | 1.19e-03 | 14 | 69 | 2 | PF00135 | |
| Domain | CarbesteraseB | 1.19e-03 | 14 | 69 | 2 | IPR002018 | |
| Domain | DHC_fam | 1.37e-03 | 15 | 69 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.37e-03 | 15 | 69 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.37e-03 | 15 | 69 | 2 | PF03028 | |
| Domain | Sulfatase_CS | 1.56e-03 | 16 | 69 | 2 | IPR024607 | |
| Domain | SULFATASE_1 | 1.76e-03 | 17 | 69 | 2 | PS00523 | |
| Domain | Peptidase_aspartic_dom | 1.76e-03 | 17 | 69 | 2 | IPR021109 | |
| Domain | SULFATASE_2 | 1.76e-03 | 17 | 69 | 2 | PS00149 | |
| Domain | Cadherin_2 | 1.79e-03 | 65 | 69 | 3 | PF08266 | |
| Domain | Cadherin_N | 1.79e-03 | 65 | 69 | 3 | IPR013164 | |
| Domain | Sulfatase | 1.98e-03 | 18 | 69 | 2 | PF00884 | |
| Domain | Sulfatase_N | 1.98e-03 | 18 | 69 | 2 | IPR000917 | |
| Domain | SEA | 2.96e-03 | 22 | 69 | 2 | PF01390 | |
| Domain | SEA | 3.24e-03 | 23 | 69 | 2 | PS50024 | |
| Domain | SEA_dom | 3.24e-03 | 23 | 69 | 2 | IPR000082 | |
| Domain | Alkaline_phosphatase_core | 5.84e-03 | 31 | 69 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 5.84e-03 | 31 | 69 | 2 | IPR017849 | |
| Domain | - | 5.84e-03 | 31 | 69 | 2 | 3.40.720.10 | |
| Domain | MAGE | 6.99e-03 | 34 | 69 | 2 | SM01373 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_DEGRADATION | 2.76e-05 | 17 | 50 | 3 | M39832 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_DEGRADATION | 5.34e-05 | 21 | 50 | 3 | M3624 | |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 1.33e-06 | 11 | 71 | 3 | 9655502 | |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 1.77e-06 | 12 | 71 | 3 | 10612399 | |
| Pubmed | 2.30e-06 | 103 | 71 | 5 | 10574462 | ||
| Pubmed | 3.64e-06 | 15 | 71 | 3 | 15640798 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 29106499 | ||
| Pubmed | Localization of retinitis pigmentosa 2 to cilia is regulated by Importin beta2. | 4.11e-06 | 2 | 71 | 2 | 21285245 | |
| Pubmed | Crystal structure of human pepsin and its complex with pepstatin. | 4.11e-06 | 2 | 71 | 2 | 7663352 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 4.11e-06 | 2 | 71 | 2 | 24104404 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 2415509 | ||
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 4.11e-06 | 2 | 71 | 2 | 32243781 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 2714789 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22989184 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 18434543 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 3197840 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 23183221 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 24855039 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 4.11e-06 | 2 | 71 | 2 | 37001827 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 4.11e-06 | 2 | 71 | 2 | 37080762 | |
| Pubmed | 5.43e-06 | 17 | 71 | 3 | 29911975 | ||
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 6.51e-06 | 18 | 71 | 3 | 10662547 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 6.51e-06 | 18 | 71 | 3 | 15570159 | |
| Pubmed | TNPO1 ARID1B COQ8A MAP6 SEC16A NFX1 OBSCN RP2 WDFY4 NUP153 BRWD1 | 1.19e-05 | 1084 | 71 | 11 | 11544199 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 2032552 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 3017318 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 18628683 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 1.23e-05 | 3 | 71 | 2 | 21989121 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 8053437 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 9855083 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 9797498 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 2478370 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 1812762 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 7923573 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 1.23e-05 | 3 | 71 | 2 | 2566575 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 1.23e-05 | 3 | 71 | 2 | 12588289 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 3815274 | ||
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 1.23e-05 | 3 | 71 | 2 | 2229438 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 1.23e-05 | 3 | 71 | 2 | 19890696 | |
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 1.23e-05 | 3 | 71 | 2 | 10675278 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 1.23e-05 | 3 | 71 | 2 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 1.23e-05 | 3 | 71 | 2 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 1.23e-05 | 3 | 71 | 2 | 1956484 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 7926498 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 8540382 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 3780036 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 9561228 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 32011705 | ||
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 1.23e-05 | 3 | 71 | 2 | 8244094 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 21455714 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 21407214 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 19800305 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 2901984 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 1.23e-05 | 3 | 71 | 2 | 20981206 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 34044070 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 1.23e-05 | 3 | 71 | 2 | 3839486 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 6774973 | ||
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 1.23e-05 | 3 | 71 | 2 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 1.23e-05 | 3 | 71 | 2 | 21970995 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 24170207 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 1.23e-05 | 3 | 71 | 2 | 22304859 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 24004680 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 8038355 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 3467902 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 4586732 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 20428942 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 1.23e-05 | 3 | 71 | 2 | 21282647 | |
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 1.23e-05 | 3 | 71 | 2 | 3014868 | |
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 1.23e-05 | 3 | 71 | 2 | 2227273 | |
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 1.23e-05 | 3 | 71 | 2 | 2892778 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 24383519 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 9525001 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 1455184 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 7886402 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 1.23e-05 | 3 | 71 | 2 | 2831884 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 23034090 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 24125879 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 26770020 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 17379991 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 1.23e-05 | 3 | 71 | 2 | 3554488 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 1.23e-05 | 3 | 71 | 2 | 2799289 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 1.23e-05 | 3 | 71 | 2 | 1968039 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 2515193 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 21547904 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 23521833 | ||
| Pubmed | 1.60e-05 | 24 | 71 | 3 | 24698270 | ||
| Pubmed | 1.76e-05 | 730 | 71 | 9 | 34857952 | ||
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 2.46e-05 | 4 | 71 | 2 | 23047493 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 16077734 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 8322031 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 17292328 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 2.46e-05 | 4 | 71 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 2.46e-05 | 4 | 71 | 2 | 22671294 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 20579107 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 2.46e-05 | 4 | 71 | 2 | 17136346 | |
| Cytoband | Xq13.3 | 4.40e-04 | 20 | 71 | 2 | Xq13.3 | |
| Cytoband | 5q31 | 7.73e-04 | 115 | 71 | 3 | 5q31 | |
| GeneFamily | Dyneins, axonemal | 8.33e-06 | 17 | 43 | 3 | 536 | |
| GeneFamily | Clustered protocadherins | 4.72e-04 | 64 | 43 | 3 | 20 | |
| GeneFamily | Sulfatases | 8.25e-04 | 18 | 43 | 2 | 410 | |
| GeneFamily | CD molecules|Mucins | 1.13e-03 | 21 | 43 | 2 | 648 | |
| GeneFamily | WD repeat domain containing | 3.41e-03 | 262 | 43 | 4 | 362 | |
| GeneFamily | MAGE family | 4.07e-03 | 40 | 43 | 2 | 1136 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 7.02e-06 | 491 | 71 | 9 | MM455 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2 | 2.30e-05 | 61 | 71 | 4 | MM869 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_100 | 1.38e-06 | 25 | 71 | 4 | gudmap_developingKidney_e13.5_podocyte cells_100_k3 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 5.44e-07 | 187 | 71 | 6 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-07 | 190 | 71 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-07 | 190 | 71 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.35e-07 | 192 | 71 | 6 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.55e-07 | 193 | 71 | 6 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-07 | 196 | 71 | 6 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 174 | 71 | 5 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.65e-06 | 174 | 71 | 5 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 182 | 71 | 5 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 182 | 71 | 5 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 184 | 71 | 5 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 187 | 71 | 5 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 1.26e-05 | 188 | 71 | 5 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-05 | 189 | 71 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.32e-05 | 190 | 71 | 5 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-05 | 191 | 71 | 5 | b680e0c35f1004be36f9f0680ae3c62952e2b607 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.43e-05 | 193 | 71 | 5 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-05 | 193 | 71 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 1.46e-05 | 194 | 71 | 5 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 195 | 71 | 5 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 196 | 71 | 5 | 023312af38f816a44b407e0daa32590d953caf99 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 196 | 71 | 5 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 196 | 71 | 5 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-05 | 196 | 71 | 5 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.58e-05 | 197 | 71 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-05 | 197 | 71 | 5 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 200 | 71 | 5 | 5ab588808c1fc384019413401ab4bf9bc06bf529 | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 200 | 71 | 5 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 200 | 71 | 5 | 6a3ccd0ea742fa76282c2b0fbc59942b4ef47bb8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.07e-04 | 154 | 71 | 4 | d22902d2922784583f7016453768ed05b14b965e | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.24e-04 | 160 | 71 | 4 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.27e-04 | 161 | 71 | 4 | 0605134a342d74ae81f33700d6ddfcd6e03aeb7b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 166 | 71 | 4 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | P15-Hematopoietic-Erythroid-enucleate_erythrocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.46e-04 | 64 | 71 | 3 | 0c000ac0f2344684ed06e27db3c9415e332a079f | |
| ToppCell | P15-Hematopoietic-Erythroid|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.46e-04 | 64 | 71 | 3 | 76f10b5420b88ad5260e5e9da656cac3875284da | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 168 | 71 | 4 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 168 | 71 | 4 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 169 | 71 | 4 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-04 | 170 | 71 | 4 | dfef8f79960979335b86b4730f224239b40735d5 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-04 | 170 | 71 | 4 | fb6098137d010175978596bc382e9ecba9c3891e | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 1.60e-04 | 171 | 71 | 4 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-04 | 172 | 71 | 4 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-04 | 175 | 71 | 4 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-04 | 177 | 71 | 4 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 1.83e-04 | 177 | 71 | 4 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 177 | 71 | 4 | 9b02fd91c110b405eba6cb74ceb90b1286535973 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 1.83e-04 | 177 | 71 | 4 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.95e-04 | 180 | 71 | 4 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.99e-04 | 181 | 71 | 4 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 182 | 71 | 4 | 63b41b538b26bc899558807fd035e543611f8c52 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 182 | 71 | 4 | 82ca6d5ed48b4c487ce00b9309255abb8f20b61d | |
| ToppCell | wk_15-18-Epithelial-PNS-Early_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.08e-04 | 183 | 71 | 4 | 7e8366ec8117d36cec67f77dcb0e9a6032d87fcb | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.08e-04 | 183 | 71 | 4 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-04 | 183 | 71 | 4 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.08e-04 | 183 | 71 | 4 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 183 | 71 | 4 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 184 | 71 | 4 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 2.12e-04 | 184 | 71 | 4 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 2.17e-04 | 185 | 71 | 4 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 185 | 71 | 4 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 2.17e-04 | 185 | 71 | 4 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 187 | 71 | 4 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-04 | 187 | 71 | 4 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.26e-04 | 187 | 71 | 4 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.26e-04 | 187 | 71 | 4 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 2.26e-04 | 187 | 71 | 4 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | Endothelial-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-04 | 187 | 71 | 4 | febe0b99a6a815ce687160a0e7af55228b1d5beb | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.31e-04 | 188 | 71 | 4 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-04 | 188 | 71 | 4 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-04 | 188 | 71 | 4 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-04 | 188 | 71 | 4 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-04 | 188 | 71 | 4 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-04 | 188 | 71 | 4 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.31e-04 | 188 | 71 | 4 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-04 | 189 | 71 | 4 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 2.35e-04 | 189 | 71 | 4 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-04 | 189 | 71 | 4 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.35e-04 | 189 | 71 | 4 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 190 | 71 | 4 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 2.40e-04 | 190 | 71 | 4 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.40e-04 | 190 | 71 | 4 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 2.40e-04 | 190 | 71 | 4 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-04 | 190 | 71 | 4 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-04 | 190 | 71 | 4 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-04 | 190 | 71 | 4 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.40e-04 | 190 | 71 | 4 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.40e-04 | 190 | 71 | 4 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-04 | 191 | 71 | 4 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 2.45e-04 | 191 | 71 | 4 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-04 | 191 | 71 | 4 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 2.45e-04 | 191 | 71 | 4 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 192 | 71 | 4 | 1ee4783051ec94ea94600f040edcb385fc4289f1 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-04 | 192 | 71 | 4 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 192 | 71 | 4 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 192 | 71 | 4 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-04 | 193 | 71 | 4 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 193 | 71 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 193 | 71 | 4 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 193 | 71 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.55e-04 | 193 | 71 | 4 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A | 2.72e-06 | 197 | 71 | 7 | 5415_DN | |
| Disease | airway responsiveness measurement | 2.29e-05 | 24 | 68 | 3 | EFO_0006897 | |
| Disease | 1,5 anhydroglucitol measurement | 4.10e-05 | 29 | 68 | 3 | EFO_0008009 | |
| Disease | neutrophil count, basophil count | 1.70e-04 | 224 | 68 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | hepcidin:transferrin saturation ratio | 5.39e-04 | 15 | 68 | 2 | EFO_0007902 | |
| Disease | Self-injurious behavior | 7.87e-04 | 78 | 68 | 3 | HP_0100716 | |
| Disease | visceral adipose tissue measurement, body mass index | 1.08e-03 | 87 | 68 | 3 | EFO_0004340, EFO_0004765 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVYEINEKNRPKDWS | 201 | Q6PI77 | |
| RDKAWNERIDRPFPA | 51 | Q8IZF5 | |
| WRREAEARKQSQPDP | 256 | Q9H0I2 | |
| ENFPRAKEFRPERWL | 451 | Q4G0S4 | |
| GAEERKWVPYRVPNN | 711 | Q8IUX7 | |
| EDVNAWERRAPLAPK | 31 | Q9UDR5 | |
| REKPSIFYQQEWPDS | 1006 | Q8TCU4 | |
| YELGNEPERKLWVDR | 1131 | Q8NFD5 | |
| PERKISFPQWEKDYN | 686 | Q32M45 | |
| QFYEDRQQLPAPKWT | 736 | P52333 | |
| DAKPRQPNPDWRYSA | 796 | Q9UN73 | |
| REDRIQLWKPPYTDE | 16 | Q9Y5A7 | |
| RKYFPQWEAPTLVDE | 51 | P0DJD9 | |
| RYQRVDEALPPNWEA | 801 | Q9P2P5 | |
| DPKSPGVDREQLYWE | 12621 | Q8WXI7 | |
| DPKSPGVDREQLYWE | 12776 | Q8WXI7 | |
| VYEDPNRLGRWLQDE | 346 | Q6TGC4 | |
| NKTWREQYLRLPDAP | 601 | Q8IYF1 | |
| WPPDRIVKQAQYEFE | 166 | Q12891 | |
| QDYLNRPRPTWEEVK | 31 | Q8N9E0 | |
| ERPLPEKEYQRQVWL | 141 | Q09470 | |
| IHRKEPQDWPQQYRE | 921 | Q9HCI5 | |
| RPQNWPEQYREAVED | 491 | Q8TD90 | |
| MRQDYRAWKVQRPEP | 121 | Q96JE9 | |
| YQKDFRAWPLPRRGD | 156 | Q96JE9 | |
| DPSRYKPQWECRENS | 406 | Q5VYM1 | |
| PEFDKQLRQWPDSYT | 151 | A0PJZ3 | |
| NEQRRYPQKRPPWEV | 236 | Q12986 | |
| AVRWLKYDEPNRQPF | 211 | Q8IXQ5 | |
| AEYPKNPRSQEWGRE | 1296 | Q9ULI3 | |
| LNDNPSPWIYRELKR | 151 | P29728 | |
| LKEPRQPNPDWRYSA | 796 | Q9Y5I0 | |
| DFRPAPKAVQWYKDD | 2491 | Q5VST9 | |
| ESFAKPRQPNPDWRY | 791 | Q9UN74 | |
| PNRFEEVAWSKYNPK | 551 | Q8NFZ3 | |
| DNKARPNIPVYRDWE | 171 | P34059 | |
| RYVDPEKQRHWLEPN | 76 | A2A2Y4 | |
| QDYLNRPRPTWEEVK | 31 | Q5BKY9 | |
| EANPKVPWDDLRYLF | 4071 | Q9UFH2 | |
| PAPLDDTQRWEYFRQ | 381 | Q9H227 | |
| RPRLPDNYTQDTWRK | 51 | Q13619 | |
| SLQPYAKRARQEFPW | 786 | Q9NSG2 | |
| GPNWRDKLEYFEERP | 321 | Q8NI60 | |
| KVLARYPENVEWNPF | 76 | Q6IQ26 | |
| RNNIYELNPNKEPWR | 981 | Q9NSI6 | |
| EEQPWEADYARKPNL | 386 | Q6IMN6 | |
| EADYARKPNLPKRWD | 391 | Q6IMN6 | |
| RDENTWYPEKNPDKL | 1746 | Q0VDD8 | |
| RRDYRPTWKLNQTEP | 756 | O00754 | |
| PQAQVRVYEPRRDCW | 141 | Q8IXV7 | |
| DRIFDISWDPYQPNR | 151 | Q6ZMW3 | |
| PVAYNPWMDIRQRED | 261 | P22304 | |
| VNRERNKKWPDLEPY | 526 | Q9P225 | |
| PNRFEEVAWSKYNPK | 551 | Q8N0W4 | |
| QQRLPEWRDPDKYCP | 26 | Q96FZ2 | |
| RKYFPQWEAPTLVDE | 51 | P0DJD7 | |
| ARRWEDLPPQAQNYI | 416 | Q8N142 | |
| WVFKDNNVEEGYPRP | 406 | Q9ULZ9 | |
| PADNEIEWNPKVTRY | 1006 | Q587J7 | |
| PPNWEKYRLFRAAQQ | 1106 | Q9ULL8 | |
| SQAPLRPEDDILYQW | 276 | Q2NL68 | |
| PVENQEKAEYEERWP | 646 | Q13018 | |
| ENWQPRARYKQSLDP | 111 | Q8N122 | |
| ISTPPEAYWNREQEK | 51 | Q9NY97 | |
| QKRNREEEWDPEYTP | 861 | Q9Y2W1 | |
| PEKRDNNWRYDPRFT | 1311 | O15027 | |
| YWNEQSAKRRVPATP | 321 | Q15035 | |
| RAEGRPRPNIEWYKN | 86 | Q96MS0 | |
| KRQPWREESGQYERK | 1116 | Q9BX66 | |
| RPENEEERPKQYSWD | 16 | O75695 | |
| DPQRNFKQWPDLEER | 806 | Q6ZS81 | |
| KADPWRVYSQDPQDL | 1151 | Q2M1Z3 | |
| PRWPENKEDHLVYAD | 76 | P49790 | |
| NWRRFSDQFPLPLKE | 876 | Q92973 | |
| LEAKRPWVEYENVRQ | 266 | Q8IY18 | |
| QLRPQQRDGKYRWEE | 1811 | Q07283 | |
| EQYDVPQEWRKEGTP | 5411 | Q9UKN1 |